Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2022-02-09 Capital/Financing Update
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Mayne Pharma expands US dermatology portfolio 1 pag
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 10 February 2022 about Mayne Pharma expanding its US dermatology portfolio by launching an authorised generic product. It contains no financial statements, no detailed financial analysis, no regulatory certifications, no voting results, no management changes, no legal proceedings, and no mention of a report being attached or published. The content is a corporate announcement about a product launch and partnership, which fits best under Capital/Financing Update (CAP) as it relates to business expansion and product portfolio growth, which can impact capital and financing outlook. The document length is short (2374 characters) and does not contain detailed financial data or report content, so it is not an Annual Report or Interim Report. Therefore, the best classification is CAP with high confidence.
2022-02-09 English
Notification of cessation of securities - MYX 4 pages 24.3KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation (lapse) of certain securities, specifically performance rights, for Mayne Pharma Group Limited. It details the number of securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement of changes in the company's issued capital related to securities that have lapsed. It does not contain financial statements, management discussion, or detailed financial results. It is not a full report but a regulatory announcement about securities status changes. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-02-09 English
Becoming a substantial holder 7 pages 307.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001, Section 671B. It details the substantial shareholding of Lazard Asset Management Pacific Co in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not a financial report, earnings release, or management report. It fits the category of Major Shareholding Notification filings, which report changes in significant share ownership levels crossing thresholds.
2022-02-01 English
Initial Director's Interest Notice 2 pages 223.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, specifically noting nil holdings and no contracts. This is a report of personal share transactions or interests by a company director. The document length is short and focused solely on director interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2022-01-31 English
Ceasing to be a substantial holder 5 pages 483.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001, detailing changes in relevant interests and associations of a substantial shareholder (Lazard Asset Management Pacific Co). It includes detailed tables of share transactions (buys and sells) and changes in voting securities. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2022-01-31 English
Non-Executive Director appointment and retirement 2 pages 156.2KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement regarding the appointment of a new non-executive director and the retirement of an existing board member. It details the professional background of the new director and acknowledges the contributions of the retiring director. There is no financial data, no mention of a report or financial results, and the content focuses solely on changes in the company's board of directors. This fits the definition of Board/Management Information (MANG). The document length is 3683 characters, which is relatively short but contains substantive information about management changes, not just a brief notice or report publication announcement.
2022-01-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.